Form 8-K - Current report:
SEC Accession No. 0001193125-21-036608
Filing Date
2021-02-11
Accepted
2021-02-10 18:55:52
Documents
11
Period of Report
2021-02-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d92624d8k.htm 8-K 29833
2 EX-4.1 d92624dex41.htm EX-4.1 98752
3 EX-5.1 d92624dex51.htm EX-5.1 26516
4 EX-5.2 d92624dex52.htm EX-5.2 14135
5 EX-10.1 d92624dex101.htm EX-10.1 164162
6 EX-99.1 d92624dex991.htm EX-99.1 10479
7 GRAPHIC g92624g0211001219971.jpg GRAPHIC 3420
8 GRAPHIC g92624g0211001424040.jpg GRAPHIC 2253
9 GRAPHIC g92624g0211015150325.jpg GRAPHIC 1579
10 GRAPHIC g92624g0211015150699.jpg GRAPHIC 1649
11 GRAPHIC g92624snap0001.jpg GRAPHIC 7033
  Complete submission text file 0001193125-21-036608.txt   367906
Mailing Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2
Business Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38503 | Film No.: 21615722
SIC: 2834 Pharmaceutical Preparations